SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
New Technology Could Improve Treatment for Diabetes, Other Disorders, Texas A&M University Study
August 16, 2012
 · 
1 min read
Lone Star Bio
Using Light to “Tag And Track” Genetic Processes Much More Efficient, University of Texas Study
August 15, 2012
 · 
1 min read
Genetown
Blood Type May Boost Heart Disease Risk, Harvard Scientific Corp. Study
August 15, 2012
 · 
4 min read
Lone Star Bio
Berlin Heart, Inc.'s Ventricular Assist Device Helped Children More Than Heart-Lung Machine
August 10, 2012
 · 
10 min read
Lone Star Bio
Students With Strong Hearts and Lungs May Make Better Grades, University of North Texas Study
August 6, 2012
 · 
1 min read
Lone Star Bio
“Spray-On Skin” Helps Heal Leg Ulcers, Healthpoint Biotherapeutics Reveals
August 3, 2012
 · 
1 min read
Lone Star Bio
New Treatment Target for Deadly Brain Tumors, UT Southwestern Medical Center Study
August 2, 2012
 · 
1 min read
Lone Star Bio
Depression Could Shorten Cancer Survival, University of Texas Study
August 2, 2012
 · 
1 min read
Lone Star Bio
Chicken Genes May Yield Cancer Fighting Substance, Texas A&M University Study
July 12, 2012
 · 
1 min read
Lone Star Bio
Hormone Curbs Depressive-Like Symptoms in Stressed Mice, University of Texas Health Science Center Study
July 10, 2012
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Press Releases
DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
June 25, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
June 25, 2026
 · 
7 min read
Press Releases
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026
 · 
3 min read
Press Releases
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 25, 2026
 · 
5 min read
Press Releases
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
June 24, 2026
 · 
5 min read
Press Releases
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
June 24, 2026
 · 
5 min read
Press Releases
Susan G. Komen® Awards $15.4 Million In Research Grants to Accelerate Breakthroughs in Breast Cancer Care
June 24, 2026
 · 
6 min read
Load More